A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma

Clinical trial NCT01454479 · UNKNOWN

Trial details

NCT number: NCT01454479
Sponsor: Hung-Hsueh Chou
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Endometrial Cancer

Start date: 2011-03-01
Primary completion: 2013-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.